Skip to main content

Jay P. McLaughlin

NIH Rank #1374
  • R01 Holder
  • Translational
  • Top 10% Funded
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1894463Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Anesthesiology
  • Pharmacology
  • Microbiology & Immunology

NIH Funding · FY2025

Linked Award Amount
$5.1M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#1,374
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Jay P. McLaughlin. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Jay P. McLaughlin as a PI. Multi-PI records show the full award amount for context.

  • 1UG3DA063363-01UG3
    Development of negative allosteric modulators at the mu opioid receptor
    $2.7M
    award amount
  • 7R01DA035714-12R01
    Molecular mechanisms: Dysregulation of monoamine transporters by HIV-1Tat and cocaine
    $728.6K
    award amount
  • 5R01DA055568-03R01
    Impacts of morphine and HIV-Tat exposures and dimethylfumarate treatment on brain BDNF and mitochondrial and behavioral dysfunction.
    $665.6K
    award amount
  • 5R01DA057790-04R01
    Targeting the allosteric sodium site with novel probes for delta opioid receptor
    $656.6K
    award amount
  • 5R01DA057884-03R01
    Function of astrocytes autophagy in brain homeostasis and opioid-induced maladaptive behavior and addiction, in the context of HIV
    $349.3K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2150
  6. 2024
    Entered Top 25% Nationally
    Ranked #2150
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Entered Top 10% Nationally
    Ranked #1374
  9. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  10. 2025
    R01 Grant Holder
  11. 2026
    $10M Cumulative Funding